Olazax Disperzi: Uses, Dosage & Side Effects

What Is Olazax Disperzi and What Is It Used For?

Olazax Disperzi is an orodispersible tablet containing the atypical antipsychotic olanzapine. It is prescribed for the treatment of schizophrenia and moderate-to-severe manic episodes in bipolar disorder, and for maintenance therapy to prevent the recurrence of manic episodes in patients who responded to initial treatment.

Olazax Disperzi is a brand name for olanzapine in orodispersible tablet form. Olanzapine is classified as a thienobenzodiazepine and is one of the most widely prescribed second-generation (atypical) antipsychotics worldwide. It is listed on the WHO Model List of Essential Medicines, reflecting its fundamental role in the global treatment of serious psychiatric disorders. Unlike older first-generation antipsychotics, which act primarily on dopamine receptors, olanzapine engages multiple neurotransmitter systems simultaneously, which is thought to contribute to its broad clinical efficacy.

The orodispersible formulation of olanzapine was developed to address a common challenge in psychiatric practice: medication adherence. Patients with acute psychosis, severe mania, or cognitive impairment sometimes refuse to swallow conventional tablets or conceal them in the mouth (a practice known as "cheeking"). Because Olazax Disperzi dissolves almost instantly on contact with saliva, it can help ensure that the full dose is actually ingested, which is why it is frequently used in inpatient psychiatric wards, emergency settings, and for patients requiring supervised administration.

Pharmacologically, olanzapine acts as an antagonist at a broad range of neurotransmitter receptors, including dopamine D1–D4 receptors, serotonin 5-HT2A and 5-HT2C receptors, muscarinic M1–M5 receptors, histamine H1 receptors, and alpha-1 adrenergic receptors. This multi-receptor profile is believed to explain both the therapeutic effects against the positive symptoms (hallucinations, delusions, disorganised thought) and negative symptoms (social withdrawal, blunted affect, reduced motivation) of psychosis, as well as several of the side effects associated with treatment.

Schizophrenia

Schizophrenia is a chronic, severe mental disorder that affects how a person thinks, feels, and behaves. People with schizophrenia may experience hallucinations (most often auditory), fixed false beliefs (delusions), suspiciousness, disorganised speech, and social withdrawal. They may also suffer from anxiety, depression, and tension. The pharmacological basis of the disorder is widely believed to involve imbalance in dopamine and serotonin neurotransmission, both of which are modulated by olanzapine.

Clinical evidence from large-scale meta-analyses, including a landmark 2019 Lancet network meta-analysis comparing 32 oral antipsychotics, consistently ranks olanzapine among the most effective agents for reducing overall symptoms of acute schizophrenia. Olazax Disperzi delivers the same olanzapine active ingredient in a rapid-onset, easy-to-administer format, which can be particularly valuable during the acute phase of illness when medication refusal is common.

Bipolar disorder — manic episodes

Bipolar disorder is characterised by dramatic mood swings between manic episodes (periods of elevated or irritable mood, increased energy, decreased need for sleep, grandiosity, and impulsive behaviour) and depressive episodes. Olazax Disperzi is used to treat moderate-to-severe manic episodes. By rapidly reducing agitation, racing thoughts, and grandiose thinking, olanzapine can bring acute mania under control and enable the patient to engage with further treatment.

Olazax Disperzi is also effective as maintenance therapy to prevent the recurrence of manic episodes in patients who responded well to olanzapine during the acute phase. Because long-term medication adherence is a key determinant of outcome in bipolar disorder, the orodispersible formulation can support consistent dosing in patients who struggle with conventional tablets.

What Should You Know Before Taking Olazax Disperzi?

Before starting Olazax Disperzi, inform your doctor about all existing medical conditions, current medications, and whether you are pregnant or breastfeeding. The active ingredient olanzapine has important contraindications, warnings, and drug interactions that must be considered to ensure safe and effective treatment.

Olanzapine is a potent medicine that affects several organ systems beyond the brain. Before starting treatment, your doctor will typically carry out a baseline assessment including weight, blood glucose, lipid profile (cholesterol and triglycerides), blood pressure, and liver function tests. These values will be monitored at regular intervals throughout treatment to detect any adverse changes early.

Your doctor should also ask about your medical history, including any heart, liver, or kidney disease, history of seizures, diabetes, Parkinson's disease, prostate problems, glaucoma, or blood disorders. A family history of these conditions may also be relevant. Be honest about your alcohol use and any use of recreational drugs, herbal supplements, or over-the-counter medicines — all of these can interact with olanzapine.

Contraindications

You should not take Olazax Disperzi if you have a known allergy (hypersensitivity) to olanzapine or to any of the other ingredients (excipients) of the tablet. An allergic reaction may present as skin rash, itching, swelling of the face or lips, or breathing difficulties. If any of these symptoms occur, stop taking the tablet and contact your doctor or seek emergency care.

Olazax Disperzi is also contraindicated in patients with a known risk of narrow-angle glaucoma, a condition in which pressure inside the eye is abnormally high. Olanzapine's anticholinergic activity can worsen this condition. If you have glaucoma or a family history of it, let your ophthalmologist and prescribing doctor know.

Warnings and precautions

A number of medical conditions require particular caution or additional monitoring when olanzapine is used. Tell your doctor if you have or have ever had any of the following:

• Stroke or transient ischaemic attack (TIA) — olanzapine may increase cerebrovascular risk, especially in the elderly
• Parkinson's disease — olanzapine may worsen Parkinsonian symptoms
• Diabetes mellitus — olanzapine can significantly raise blood glucose levels and may precipitate diabetic ketoacidosis in susceptible patients
• Heart disease — including arrhythmias, heart failure, or a recent myocardial infarction
• Liver disease — dose adjustment may be necessary; caution is needed in patients with significantly elevated liver enzymes
• Kidney disease — olanzapine is primarily cleared by the liver, but caution is still advised
• Epilepsy or history of seizures — olanzapine can lower the seizure threshold
• Prostate problems — urinary retention may occur
• Bowel obstruction (paralytic ileus)
• Blood disorders — olanzapine may affect white blood cell counts
• History of blood clots (venous thromboembolism) or risk factors such as immobilisation or obesity

Patients over 65 years of age should have their blood pressure monitored regularly during treatment, as olanzapine can cause orthostatic hypotension (a drop in blood pressure when standing), which increases the risk of falls and fractures.

Children and adolescents

Olazax Disperzi is not intended for use in patients under 18 years of age. Clinical data on the safety and efficacy of olanzapine in children and adolescents are limited, and the metabolic side effects (weight gain and changes in glucose and lipid levels) appear to be more pronounced in younger patients than in adults. If an antipsychotic is needed for a child or adolescent, the prescribing doctor will generally consider age-appropriate alternatives.

Pregnancy and breastfeeding

If you are pregnant, think you may be pregnant, or are planning to become pregnant, consult your doctor before taking Olazax Disperzi. Olanzapine should only be used during pregnancy if the potential benefits to the mother clearly outweigh the potential risks to the foetus. Olanzapine is not a known teratogen, but the quantity of controlled data in pregnant women remains limited, and untreated serious psychiatric illness also poses substantial risks to both mother and baby.

Newborns whose mothers took olanzapine during the third trimester may experience withdrawal symptoms including tremor, muscle stiffness or weakness, sleepiness, agitation, breathing difficulties, and feeding problems. If your baby develops any of these symptoms after birth, contact your doctor promptly.

Small amounts of olanzapine pass into breast milk. Breastfeeding is not recommended during treatment with Olazax Disperzi. If breastfeeding is a priority for the mother, alternative medications or feeding strategies should be discussed with the psychiatric and obstetric teams.

Driving and operating machinery

Olanzapine can cause drowsiness, dizziness, and blurred vision, particularly during the early phase of treatment or after a dose increase. Do not drive, cycle, or operate heavy machinery until you are confident of how Olazax Disperzi affects you. If daytime drowsiness persists, discuss this with your doctor — adjusting the timing of the dose (for example, taking it in the evening) or the dose itself may help.

How Does Olazax Disperzi Interact with Other Drugs?

Olazax Disperzi interacts with several medications that can increase or decrease olanzapine levels or add to its side effects. Key interactions include carbamazepine, fluvoxamine, ciprofloxacin, benzodiazepines, dopamine agonists, and alcohol. Always inform your doctor and pharmacist of every medicine you take.

Drug interactions with olanzapine can arise through several mechanisms. The most important involve the liver enzymes that metabolise olanzapine — primarily CYP1A2 and to a lesser extent CYP2D6. Medications, foods, or lifestyle factors that induce or inhibit these enzymes can change the concentration of olanzapine in the blood. Additional interactions involve additive pharmacological effects on the central nervous system, blood pressure, and the heart.

Your doctor and pharmacist should know about every prescription medicine, over-the-counter product, and herbal supplement you use before starting Olazax Disperzi. Keep a current list with you and review it at each medical appointment.

Major interactions

The following interactions are clinically significant and often require dose adjustments, close monitoring, or avoidance:

Other notable interactions

Alcohol: Do not consume alcohol while taking Olazax Disperzi. The combination can cause excessive drowsiness, impaired judgement, and respiratory depression. Alcohol also worsens many of the side effects of olanzapine and can undermine the stability needed for psychiatric recovery.

Antidepressants and anxiolytics: Co-administration of olanzapine with certain antidepressants or anti-anxiety medications may increase sedation and orthostatic hypotension. Your doctor may adjust the dose of either medication to minimise these effects.

Antihypertensives: Olanzapine can lower blood pressure. When combined with blood-pressure-lowering medications, excessive hypotension may occur, particularly during dose titration. Blood pressure monitoring is recommended, especially during the first weeks of combined treatment.

Smoking: Tobacco smoking induces CYP1A2, which metabolises olanzapine. Patients who smoke typically require higher doses to achieve the same blood levels. If you stop smoking during treatment, olanzapine levels may rise and dose reduction may be necessary. Tell your doctor about any change in smoking habits.

QT-prolonging drugs: While olanzapine itself has a modest effect on the QT interval, combining it with other QT-prolonging agents (certain antiarrhythmics, some antibiotics, methadone) may increase the risk of arrhythmias. Your doctor may order an ECG before and during treatment if you take such combinations.

What Is the Correct Dosage of Olazax Disperzi?

The typical adult dose of olanzapine ranges from 5 mg to 20 mg taken once daily. Olazax Disperzi is supplied as 5 mg orodispersible tablets, which can be combined to reach higher doses when needed. The starting dose depends on the condition being treated, and the dose should be taken exactly as prescribed.

The dose of Olazax Disperzi is individualised by your prescribing doctor based on your specific diagnosis, symptom severity, age, co-existing medical conditions, and other medications. Olanzapine is taken once daily, at the same time each day, with or without food. Treatment duration is determined by your doctor and may be long-term for chronic conditions such as schizophrenia.

Adults

Dose adjustments should be made at intervals of no less than 24 hours, typically in increments of 5 mg. Your doctor will aim to find the lowest effective dose that controls your symptoms while minimising side effects.

Elderly patients

A lower starting dose of 5 mg/day — conveniently provided by a single Olazax Disperzi 5 mg orodispersible tablet — may be considered in elderly patients, particularly those over 65 years. Dose increases should be made more cautiously, with close monitoring for orthostatic hypotension, sedation, and risk of falls. As noted above, olanzapine is not recommended for elderly patients with dementia-related psychosis.

Patients with liver or kidney impairment

A lower starting dose of 5 mg/day should be considered in patients with moderate hepatic (liver) impairment. Dose escalation should be cautious. Olanzapine has not been studied systematically in patients with severe hepatic impairment. Renal (kidney) impairment does not generally require dose adjustment, but lower starting doses and careful titration are prudent in patients with significant renal disease or in those who are frail.

How to take Olazax Disperzi orodispersible tablets

Olazax Disperzi orodispersible tablets are designed to dissolve rapidly on the tongue and should be handled with care to prevent the tablet from breaking or dissolving prematurely:

1. Handle the tablet with dry hands — moisture will cause premature dissolution
2. Peel back the blister foil carefully; do not push the tablet through the foil, as it may crumble
3. Ensure your mouth is empty, then place the tablet on your tongue immediately after removing it from the packaging
4. The tablet will disintegrate within seconds in your saliva and can be swallowed with or without water
5. Alternatively, the tablet may be dispersed in a full glass of water, orange juice, apple juice, milk, or coffee and drunk immediately

You do not need to take Olazax Disperzi with food, although taking it at roughly the same time each day helps establish a routine and supports adherence.

Missed dose

If you forget to take your Olazax Disperzi, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a forgotten one. If you miss several doses in a row, contact your doctor before restarting treatment, as it may be advisable to re-titrate to minimise side effects.

Overdose

What Are the Side Effects of Olazax Disperzi?

Like all medications, Olazax Disperzi can cause side effects, though not everyone experiences them. The most common side effects are weight gain, drowsiness, and increased prolactin levels. Serious but rare effects include neuroleptic malignant syndrome, tardive dyskinesia, and venous thromboembolism. Report any concerning symptoms to your doctor.

The side effects of Olazax Disperzi are those of its active ingredient, olanzapine. They range from mild and transient to serious and potentially life-threatening. The metabolic effects — weight gain, altered glucose metabolism, and changes in blood lipids — are among the most clinically important and require ongoing monitoring throughout treatment. Many of the common side effects, such as drowsiness and dizziness, tend to be most pronounced at the start of treatment or after dose increases, and may improve over time.

Patients with Parkinson's disease

Olanzapine may worsen the motor symptoms of Parkinson's disease. If you have Parkinson's disease and are prescribed Olazax Disperzi, your doctor will monitor you closely for any deterioration of your Parkinsonian symptoms. In many cases, alternative antipsychotics with a lower risk of extrapyramidal side effects (such as quetiapine or clozapine) are preferred in this population.

What Happens If You Stop Taking Olazax Disperzi?

Do not stop Olazax Disperzi abruptly. Sudden discontinuation can cause withdrawal symptoms including sweating, insomnia, tremor, anxiety, nausea, and vomiting. It also significantly raises the risk of relapse. Your doctor will recommend a gradual dose reduction when it is appropriate to stop.

It is essential to continue taking Olazax Disperzi as prescribed, even if you feel better. Many psychiatric conditions are chronic, and stopping medication prematurely markedly increases the risk of relapse. Studies show that patients with schizophrenia who discontinue antipsychotic treatment have relapse rates of 60–80% within a year, compared with 20–30% for those who continue maintenance therapy.

If you and your doctor decide to discontinue Olazax Disperzi, the dose should be reduced gradually over several weeks rather than stopped suddenly. Abrupt cessation may cause discontinuation symptoms including:

• Excessive sweating
• Difficulty sleeping (insomnia)
• Tremor and shaking
• Anxiety and irritability
• Nausea and vomiting
• Rebound psychotic symptoms

Your doctor will design a tapering schedule tailored to your situation, typically reducing the dose by small increments every 1–2 weeks while monitoring for any return of symptoms or withdrawal effects. Using Olazax Disperzi 5 mg orodispersible tablets can make controlled stepwise tapering more straightforward than splitting larger tablets.

How Should You Store Olazax Disperzi?

Store Olazax Disperzi in its original packaging, away from light and moisture, at room temperature. Keep out of sight and reach of children. Do not use after the expiry date printed on the packaging.

Proper storage of Olazax Disperzi is especially important because the orodispersible tablet is sensitive to moisture. Follow these storage guidelines to ensure the tablets remain effective and safe throughout their shelf life:

• Keep in the original blister pack until ready to take the tablet — the blister protects the tablets from light and moisture
• Store at room temperature (below 25 °C / 77 °F) — avoid extreme heat or cold
• Protect from light — do not remove tablets from the blister pack in advance
• Protect from moisture — do not store in the bathroom; orodispersible tablets dissolve on contact with water
• Keep out of sight and reach of children and pets
• Check the expiry date printed on the outer carton and blister; the expiry date refers to the last day of that month

Do not dispose of unused or expired Olazax Disperzi via household waste or down the drain. Return them to your pharmacist for safe disposal. This helps protect the environment and prevents accidental exposure of others.

What Does Olazax Disperzi Contain?

The active ingredient is olanzapine. Olazax Disperzi is available as a 5 mg orodispersible tablet. Typical inactive ingredients (excipients) include mannitol, microcrystalline cellulose, crospovidone, and magnesium stearate. Some formulations contain aspartame — check the leaflet if you have phenylketonuria.

Each Olazax Disperzi orodispersible tablet contains the active ingredient olanzapine in the strength specified on the packaging (5 mg). The inactive ingredients (excipients) serve several pharmaceutical purposes such as binding the tablet together, enabling rapid disintegration in the mouth, and improving taste and mouthfeel.

Active ingredient

• Olanzapine — 5 mg per orodispersible tablet

Common excipients in orodispersible olanzapine formulations

• Mannitol — sweetener and bulking agent, helps the tablet disintegrate quickly in the mouth
• Microcrystalline cellulose — binder and filler
• Crospovidone — disintegrant that enables the tablet to break apart rapidly
• Low-substituted hydroxypropyl cellulose — binder
• Magnesium stearate — lubricant for the manufacturing process
• Calcium silicate — flow agent
• Aspartame (in some formulations) — sweetener
• Flavourings — to improve taste during in-mouth dissolution

Olanzapine is available worldwide under many brand names, including Zyprexa and Zyprexa Velotab (the original brands), Olazax and Olazax Disperzi, Zalasta, Olanzapine Accord, Olanzapine Teva, Olanzapine Sandoz, Olanzapine Actavis, Olanzapine SUN, and Olanzapine Viatris, among others. All approved generic versions must demonstrate bioequivalence to the originator product to receive marketing authorisation, which means they are expected to produce the same clinical effect when taken at the same dose.